Bill No. 552, introduced by Hines in the Senate and Duel in the House, aims to enhance public safety by regulating the use of biotechnology by state agencies. The bill defines key terms, including "biotechnology company of concern," which refers to entities under the control of foreign adversaries that pose national security risks due to their research in multiomic data collection. Additionally, "multiomics" is defined as a method of biological analysis that integrates data from various research fields to understand complex biological processes.

Under the provisions of the bill, any state agency that receives federal or state funds is prohibited from using or procuring biotechnology equipment or services from companies designated as biotechnology companies of concern. Furthermore, these agencies are not allowed to contract with entities that utilize such biotechnology. The act is set to take effect only upon the enactment of a federal law that similarly restricts entities receiving federal funds from using biotechnology associated with foreign adversaries.